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Chondrogenesis during embryonic skeletal development involves the condensation of mesenchymal cells followed by their
differentiation into chondrocytes. We describe herein a previously unrecognized regulator of mammalian chondrogenesis
encoded by a murine growth factor-inducible immediate-early gene, cyr61. The Cyr61 protein is a secreted, heparin-binding
protein (379 amino acids with 38 conserved cysteines) that promotes cell adhesion, migration, and proliferation. The
expression pattern of the cyr61 gene during embryogenesis is tissue speci®c and temporally regulated. Most notably, cyr61
is transiently expressed in mesenchymal cells of both mesodermal and neuroectodermal origins undergoing chondrogenesis,
suggesting that Cyr61 may play a role in the development of the embryonic skeleton. In this communication, we demon-
strate that the Cyr61 protein promotes chondrogenesis in micromass cultures of limb bud mesenchymal cells in vitro and
is likely to play a similar role in vivo based on the following observations: (1) Cyr61 is present in the embryonic limb
mesenchyme during chondrogenesis in vivo and in vitro; (2) puri®ed recombinant Cyr61 protein added exogenously to
micromass cultures promotes chondrogenesis as judged by precocious expression of type II collagen, increased [35S]sulfate
incorporation, and larger Alcian blue-staining cartilage nodules; (3) Cyr61 enhances cell±cell aggregation, an initial step
in chondrogenesis, and promotes chondrogenic differentiation in cultures plated at subthreshold cell densities that are
otherwise unable to support differentiation; and (4) neutralization of the endogenous Cyr61 with speci®c antibodies inhibits
chondrogenesis. Taken together, these results identify Cyr61 as a novel player in chondrogenesis that contributes to the
development of the mammalian embryonic skeleton. q 1997 Academic Press
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INTRODUCTION one such immediate-early gene, cyr61 (O'Brien et al., 1990),
encodes a previously unrecognized regulator of mammalian
chondrogenesis.Polypeptide growth factors are involved in the regulation
cyr61 is transcriptionally activated by serum growth fac-of many cellular processes in development, including cell
tors, including ®broblast growth factor (FGF), platelet-de-migration, proliferation, and differentiation (Sporn and Rob-
rived growth factor, and TGFb, and encodes a secreted hepa-erts, 1990; Mercola and Stiles, 1988). Exposure of responsive
rin-binding protein of 379 aa (Brunner et al., 1991; O'Briencells to growth factors results in the rapid and transient
et al., 1990; Yang and Lau, 1991; Lau and Nathans, 1987).activation of a set of immediate-early genes without requir-
The Cyr61 protein is a member of an emerging family ofing de novo protein synthesis (Lau and Nathans, 1991;
extracellular proteins characterized by signi®cant sequenceHerschman, 1991; Williams et al., 1992). These immediate-
homology and conservation of all 38 cysteine residues inearly genes encode proteins that are believed to mediate the
their secreted portions (O'Brien and Lau, 1992; Bork, 1993).biological responses of recipient cells to the growth factors.
This protein family, called the CCN family (Cyr61/CEF10,In this report, we describe evidence for the ®nding that
CTGF/Fisp12, Nov) (Bork, 1993), includes three distinct
members to date: (1) the murine Cyr61 and its chicken ho-
molog, CEF-10 (Simmons et al., 1989); (2) the human con-1 To whom correspondence should be addressed. Fax: (312) 996-
7034. nective tissue growth factor (CTGF) (Bradham et al., 1991)
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and its murine homolog, Fisp12 (Ryseck et al., 1991); and cromass'' cultures differentiate into cartilage in vitro in a
manner that mimics the differentiation process in vivo (Ah-(3) Nov, whose gene was identi®ed as aberrantly expressed
in retrovirus-induced avian nephroblastomas (Joliot et al., rens et al., 1977; Solursh, 1984). Therefore, this cell system
has been utilized extensively to study chondrogenic differ-1992). Although the biological functions of the CCN family
members remain to be elucidated, growth factor and proto- entiation. Studies in the micromass system revealed that
the initial mesenchymal condensations, which result fromoncogenic activities have been reported for CTGF (Bradham
et al., 1991) and Nov (Joliot et al., 1992), respectively. The intercellular aggregation rather than localized cell prolifera-
tion (Thorogood and Hinchliffe, 1975), involve the actionsDrosophila genes twisted gastrulation (tsg) (Mason et al.,
1994) and short gastrulation (sog) (Francois et al., 1994), of several endogenously expressed proteins, including ®-
bronectin (Downie and Newman, 1995; Zanetti et al., 1990;which interact genetically with decapentaplegic (dpp) to
regulate dorsal±ventral patterning, also share sequence sim- Swalla and Solursh, 1984), tenascin (Mackie et al., 1987),
neural cell adhesion molecules (NCAM) (Widelitz et al.,ilarities with members of this gene family. These ®ndings
provided clues that Cyr61 and its family members may play 1993), and N-cadherin (Oberlender and Tuan, 1994).
Whether these molecules are involved exclusively in cellroles in regulating growth and differentiation in develop-
ment. aggregation or whether they also signal through speci®c
mechanisms to induce chondrogenesis is currently un-Biochemical and cell biological studies showed that the
Cyr61 protein is secreted and associated with the extracellu- known. In addition, a number of endogenously expressed
signaling proteins that regulate morphogenesis and tissuelar matrix (ECM) and the cell surface (Yang and Lau, 1991).
Puri®ed recombinant Cyr61 mediates cell adhesion, stimu- patterning, including members of the TGFb superfamily,
have been shown to modulate chondrogenesis in the mesen-lates cell migration, and enhances growth factor-induced
DNA synthesis (Kireeva et al., 1996, 1997). These activities chymal cell micromass system (Leonard et al., 1991; Jiang
et al., 1993).suggest that Cyr61 may regulate cellular responses upon
growth factor treatment, including proliferation and differ- In this study, we show that the immediate-early gene
product Cyr61 plays a role in mammalian chondrogenesis.entiation. Moreover, the cyr61 gene is temporally regulated
in a tissue-speci®c manner during embryonic development. Cyr61 is localized to the limb bud mesenchyme in vivo and
in vitro during chondrogenic differentiation. In the micro-Expression of cyr61 during embyrogenesis, shown by in situ
hybridization, occurs transiently in the mesenchymal con- mass culture system, puri®ed Cyr61 protein is able to: (1)
promote precocious mesenchymal cell aggregation; (2) ac-densations of both mesodermal and neuroectodermal ori-
gins as they differentiate into chondrocytes (O'Brien and celerate the expression of type II collagen, indicative of dif-
ferentiation into chondroblasts; (3) enhance subsequentLau, 1992). Furthermore, cyr61 expression occurs in the so-
mites in a craniocaudal progression, coincident with their expansion of cartilage nodules and synthesis of cartilage-
speci®c matrix; and (4) support chondrogenesis in cellschondrogenic differentiation (O'Brien and Lau, 1992). Taken
together, the activities of Cyr61 protein in cultured cells plated at subthreshold densities. Furthermore, anti-Cyr61
antibodies directed against the endogenous Cyr61 proteinand the dynamic and restricted expression pattern of its
gene in the mouse suggest that Cyr61 may play a role in inhibited chondrogenesis. Taken together, these results
identify Cyr61 as a novel participant in regulating cartilageskeletal development.
Development of the embryonic skeleton depends upon formation during mammalian skeletal development.
the interplay between a complex array of signaling mole-
cules to coordinate the processes of growth, differentiation,
and patterning (Eriebacher et al., 1995; Tabin, 1995; Johnson MATERIALS AND METHODS
and Tabin, 1997). Mesenchymal cells migrate from the
mesoderm and the neural crest to form condensations that
Cell culture. Mesenchymal cells were isolated from the limb
differentiate into cartilaginous anlages of future skeletal el- buds of gestational day 10.5 (vaginal plug  day 0.5) NCD-1 strain
ements, forming the axial/appendicular and craniofacial mouse embryos (Harlan Sprague±Dawley) and plated in micromass
skeleton, respectively (Solursh, 1984). The limb bud is a culture using a modi®cation of a published procedure (Ahrens et
self-organizing structure, which expresses a number of en- al., 1977). Brie¯y, isolated limb buds were digested with 1 mg/ml
porcine pancreatic trypsin (Sigma type 1:250) in calcium±magne-dogenous factors that govern its morphogenesis and pat-
sium-free saline with 56 mM glucose and 1 mg/ml EDTA (pH 7.4).terning (Eriebacher et al., 1995; Tabin, 1995). The initial
Limb mesenchymal cells were dissociated by pipetting after neu-steps of cell±cell aggregation to form mesenchymal conden-
tralization of enzymatic activity with serum, and the cell suspen-sation are modulated by cell adhesion molecules (Widelitz
sion was ®ltered through a 20-mm-mesh Nitex ®lter (Tetko, Inc.).et al., 1993; Oberlender and Tuan, 1994), followed by the
Cells were plated in 24-well plates (Corning) at suspension densi-differentiation of these condensed cell aggregates into chon-
ties ranging from 2.5 to 10 1 106 cells/ml, with one 10-ml drop per
droblasts, which express type II collagen (Dessau et al., well, and were allowed to attach for 2 h at 377C, 5% CO2, before
1980; Castagnola et al., 1988). The chondroblasts then ter- addition of culture medium (1 ml/well). For the ®rst 24 h of culture,
minally differentiate into chondrocytes, marked by the syn- the culture medium consisted of 10% fetal bovine serum (FBS;
thesis of sulfated proteoglycans (Solursh, 1991). Sigma) in minimal essential medium (MEM; Gibco BRL), supple-
mented with penicillin (100 U/ml) and streptomycin (100 mg/ml).Limb bud mesenchymal cells plated in high density ``mi-
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NuSerum (Collaborative Biomedical Products), which contains to 1:100 with 3% bovine serum albumin (BSA) in 11 PBS. Mouse
IgG (0.01 mg/ml) was used in control sections. All sections were25% FBS in the undiluted formulation, when used after the ®rst
incubated with biotinylated goat anti-mouse IgG secondary anti-24 h of culture, was found to support mouse limb mesenchymal
body (5 mg/ml in 3% BSA/11 PBS) for 45 min at room temperature,cell growth and differentiation to an extent similar to that of FBS
followed by horseradish peroxidase-conjugated streptavidin (5 mg/(unpublished observations). After 24 h, the medium was changed
ml in 3% BSA/11 PBS) for 15 min. Antibody binding was visualizedto 4% NuSerum in MEM with the same antibiotics, resulting in a
with a commercial staining kit (Zymed) employing hydrogen perox-®nal serum concentration of 1%. The medium was supplemented
ide as the substrate and diaminobenzidine as the chromogen. Sec-with various additives as indicated at this time. Cells were incu-
tions were counterstained with Mayer's hematoxylin, rinsed in tapbated at 377C, 5% CO2 for 4 or 8 days. In the 8-day cultures, the
water, dehydrated, and mounted with Permount.media, including supplements, were changed on culture day 4.
For immunohistochemical localization of Cyr61 in vitro, limbCyr61 protein and anti-Cyr61 antibodies. Recombinant, bio-
mesenchymal cells were grown in micromass culture, as describedlogically active mouse Cyr61 protein was puri®ed from serum-free
above, on glass coverslips (Fisher) for 3 days. Cultures were ®xedconditioned media of Sf9 insect cells infected with a baculovirus
in 4% paraformaldehyde in PBS, incubated with hyaluronidase asdriving the synthesis of Cyr61 as described (Kireeva et al., 1996).
above, blocked with 10% goat serum in PBS, and incubated over-Af®nity-puri®ed anti-Cyr61 antibodies (used in Figs. 2, 3, 5, and 10)
night at 47C with primary antibodies against Cyr61 (Yang and Lau,were prepared as described (Yang and Lau, 1991). For localization
1991), ®bronectin (Gibco), and tenascin (Gibco). Controls were in-of Cyr61 in embyro sections by immunohistochemistry (Fig. 1), a
cubated with anti-Cyr61 antibodies neutralized with 1 mg/ml puri-monoclonal antibody against the human CYR61 protein was used
®ed Cyr61. Cultures were subsequently incubated with FITC-con-(Kolesnikova and Lau, 1998; Kolesnikova, 1997). Brie¯y, the human
jugated goat anti-rabbit secondary antibody (Zymed), for 1 h atCYR61 cDNA was cloned and the encoded hCYR61 (91% overall
room temperature.amino acid sequence identity with the mouse Cyr61 with stretches
of complete sequence identity) was puri®ed from a baculovirus Adhesion of mesenchymal cells to extracellular matrix proteins.
Cyr61, ®bronectin (Gibco), or tenascin (Gibco) were diluted in 0.1%expression system (Kolesnikova and Lau, 1997; Kolesnikova, 1997)
using a procedure similar to that for the mouse Cyr61 (Kireeva et protease-free BSA in PBS with 0.5 mM PMSF, to ®nal concentra-
tions of 10 or 50 mg/ml. A 10-ml drop/well was placed in a non-al., 1996). The puri®ed hCYR61 protein was used to immunize
mice, and production of hybridomas was carried out by the Immu- tissue culture-treated 24-well plate (Corning) and incubated at
room temperature for 2 h. The wells were blocked with 1% BSAnological Resources Center of the University of Illinois at Urbana±
Champaign following standard procedures (Harlow and Lane, in PBS for 1 h at room temperature and rinsed with serum-free
MEM. Limb mesenchymal cells, suspended at 5 1 105 cell/ml in1988). Hybridomas were screened by ELISA, and several positive
clones were expanded as ascites. One of these, mAbIII, was partially serum-free MEM, were added at a volume of 400 ml/well and incu-
bated at 377C, 5% CO2 for 1 or 3 h. At each time point, the cellpuri®ed by ammonium sulfate precipitation; mAbIII is speci®c for
the CYR61 protein, although it reacts with both the human and suspension was removed, the wells were rinsed with MEM, and
the remaining adherent cells were photographed.the mouse Cyr61 indifferently (data not shown).
Immunoblotting. Limb mesenchymal cells (5 1 106 cells/ml) Aggregation of mesenchymal cells in suspension. After en-
zymatic digestion of mesenchymal cells, as described above,were plated in 10-ml spots on 60-mm petri dishes (Corning), with
at least 30 spots/dish, for Western analysis. On each day of culture, trypsin activity was neutralized with soybean trypsin inhibitor
(1 mg/ml). Cells were resuspended in serum-free MEM after cen-one dish was rinsed with phosphate-buffered saline (PBS), and the
cell layer was scraped and collected into 0.25 ml radioimmunopre- trifugation (10 s, 500 rpm) and passed through a 27-gauge needle
to obtain a single-cell suspension. Cells were incubated at 377C,cipitation assay buffer [50 mM Tris, pH 8.0; 150 mM NaCl, 0.1%
sodium dodecyl sulfate (SDS); 0.5% deoxycholate; 1% Nonidet P- 5% CO2, with constant gentle rocking, at a concentration of
106 cell/ml in non-tissue culture-treated 24-well plates. Af®nity-40], supplemented with the protease inhibitors phenymethylsulfo-
nyl ¯uoride (PMSF; 1 mM), pepstatin (1 mg/ml), leupeptin (1 mg/ puri®ed anti-Cyr61 antibodies (8 ml/well) were added to the sus-
pension cultures either directly or after a 1-h preincubation atml), apotinin (1 mg/ml), aminocaproic acid (50 mM), benzamidine
(5 mM), and EDTA (1 mM). Cell suspensions were sheared through room temperature with an equal volume of puri®ed Cyr61 pro-
tein (1 mg/ml). Controls included preincubation of either Cyr61an 18-gauge needle, centrifuged at 14,000 rpm to remove debris,
and stored at 0807C. Total protein concentration was determined storage buffer or puri®ed Cyr61 protein (1 mg/ml), with either
rabbit IgG (0.1 mg/ml) or 50 mM Tris±0.1 M glycine buffer (pHin the supernatants by the Lowry method using a commercially
available kit (Bio-Rad). Protein samples (15 mg) were separated on 7.5), used in the af®nity puri®cation of the anti-Cyr61 antibodies
(Yang and Lau, 1991). Aggregation was also determined in un-an SDS±polyacrylamide gel (10%). Immunoblotting was performed
with af®nity-puri®ed anti-Cyr61 antibodies as described (Yang and treated control cells. At successive time points, the number of
single cells was counted in three ®elds per well, in each of threeLau, 1991), followed by detection of proteins with enhanced chemi-
luminescence reagents (Amersham). to six wells per treatment group. Values reported are the number
of single cells remaining at sequential time points, expressed asImmunohistochemistry. For immunohistochemical localiza-
a mean percentage of the number at time 0.tion of Cyr61 in vivo, mouse embryos from gestational day 13 were
®xed in 4% paraformaldehyde in 11 PBS for 24 h, dehydrated in Treatment of micromass cultures with Cyr61 or anti-Cyr61 an-
tibodies. The puri®ed protein was stored in aliquots at 0807C inethanol, and embedded in paraf®n. Embryonic limbs were sec-
tioned at 10 mm and rehydrated with 11 PBS. Endogenous peroxi- a buffer containing 10% glycerol (v/v) in 50 mM MES, pH 6.0, 150
mM NaCl, 2 mM EDTA, 1 mM PMSF, adjusted to a ®nal pH ofdase activity was quenched with PeroxoBlock (Zymed, South San
Francisco, CA) for 2 min, and sections were incubated with 2 mg/ 7.5 with 1 M Tris (pH 8.5) and was thawed immediately prior to
addition to culture media on culture day 1 (24 h after plating).ml bovine testicular hyauronidase (type IV; Sigma) in 0.1 N sodium
acetate (pH 5.5) for 30 min at room temperature. Sections were Where controls were indicated, cultures were supplemented with
an equal volume of the corresponding buffer. Af®nity-puri®ed anti-incubated overnight at 47C with mAbIII against hCYR61, diluted
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FIG. 1. Immunohistochemical localization of Cyr61 in the mouse embryo. Paraf®n sections (10 mm) of gestational day 13.5 mouse
embryos were incubated with either control mouse IgG (A and C) or the monoclonal antibody mAbIII against hCYR61 (B, D, E, and F)
and counterstained with Mayer's hematoxylin. Staining for Cyr61 is seen in the perichondrum (p), cartilage (c), and loose mesenchyme
(m) in serial longitudinal sections of the forelimb digits (A and B). Similar staining was observed in serial transverse sections of the distal
end of the humerus (C and D). Cyr61 staining was present in all cartilaginous anlages of the forelimb, shown in lower magni®cation (E).
In a sagittal section of the mouse embryo (F), Cyr61 staining is present in the more mature vertebral cartilage in the cranial region (1)
and the less mature somitic condensations in the caudal region (2). Bar, 50 mm (A±D); 300 mm (E and F).
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Cyr61 antibodies (O'Brien et al., 1990; Yang and Lau, 1991) were
either added at 10 or 13 ml/ml of culture media at the time of
plating or mixed with cells at a volume of 3 ml of antibodies to 60
ml cell suspension prior to plating. Controls were similarly treated
with an equal volume of rabbit IgG at 0.1 mg/ml (Gibco). Where
indicated, anti-Cyr61 antibodies were incubated with an equal vol-
ume of puri®ed Cyr61 protein (1 mg/ml) at room temperature for 1
h, and 6 ml of the antibodies±Cyr61 mixture was mixed with 60
ml of cell suspension. Controls included preincubation of (a) Cyr61
storage buffer with rabbit IgG or anti-Cyr61 antibodies and (b) 50
mM Tris±0.1 M glycine buffer (pH 7.5) with puri®ed Cyr61 or
Cyr61 storage buffer.
Determination of cell proliferation. Cell proliferation during
the 4-day culture period was determined by counting cell number
and by incorporation of [3H]thymidine. To determine cell number,
cells were harvested by trypsin/EDTA (Sigma) and counted with a
Coulter counter. In parallel cultures, [3H]thymidine (1 mCi/ml;
ICN) was added to the media for 18 h and incorporation in the TCA-
insoluble layer was determined by liquid scintillation counting.
Assessment of chondrogenesis in micromass cultures. Chondro-
genic differentiation was quantitated by incorporation of [35S]- FIG. 2. Expression of Cyr61 in limb mesenchymal cells. (A) Total
sulfate (ICN) into sulfated glycosaminoglycans and assessed quali- cell extracts of limb mesenchymal cells from gestational day 10.5
tatively by Alcian blue staining. Cultures were radiolabeled with mouse embryos in micromass cultures were separated by SDS±
2.5 mCi/ml [35S]sulfate for 18 h, ®xed with Kahle's ®xative, and 10% polyacrylamide gel, followed by Western blot analysis probed
stained with 0.5% Alcian blue, pH 1.0 (Lev and Spicer, 1964). The with anti-Cyr61 antibodies. Lanes 1±4 display mesenchymal cell
extent of chondrogenesis is correlated with the intensity of Alcian proteins of day 1±4 cultures, respectively (15 mg total protein per
blue staining (San Antonio and Tuan, 1986). [35S]Sulfate incorpora- lane). Cell extracts from 1-h serum-stimulated (lane 5) and quies-
tion in the ®xed cell layer was quantitiated by liquid scintillation cent (lane 6) NIH 3T3 ®broblasts (15 mg total protein) show the
counting. serum-stimulated Cyr61 protein band. Molecular masses of marker
RNA blot analysis. Limb bud mesenchymal cells were cultured proteins are indicated on the left in kilodaltons. (B) Puri®ed Cyr61
for 1 to 4 days in 1% NuSerum-containing media supplemented protein (2 mg) was separated by 10% SDS gel electrophoresis and
with 5 mg/ml Cyr61 or an equivalent volume of buffer. Total RNA stained with Coomassie blue.
was extracted from cultures of 3±5 1 106 cells using Trizol reagent
(Gibco), and 15 mg of total RNA per lane was electrophoresed in a
1% agarose±formaldehyde gel and transferred to a nylon membrane
as described (Ausubel et al., 1994). The blot was exposed to UV chemically localized to chondrogenic sites during em-
light to immobilize the RNA and hybridized to radioactively la- bryogenesis (Fig. 1). In the gestational day 13 mouse embryo,
beled cDNA probe of the a1 chain of mouse type II collagen (Mets- Cyr61 was found in the maturing cartilage and perichon-
aranta et al., 1991). Intensity of bound probe was determined by
drium of the digits in the forelimb (Figs. 1B and 1E). Theexposure to a phosphorimager screen for 24 h, and analyzed by the
most intense Cyr61 staining was in the perichondrium, al-ImageQuant program (Molecular Dynamics). After the ®rst probe
though the interdigital mesenchyme also stained for Cyr61.was stripped, the blot was rehybridized with cDNA against b-tu-
A similar staining pattern was also seen in a section of thebulin. Both cDNA probes were linearized and labeled with [32P]-
dCTP using the random-prime labeling procedure. distal end of the humerus (Fig. 1D). At a lower magni®ca-
Statistical analysis. In each experiment, statistical differences tion, Cyr61 staining was observed in all the skeletal anlages
between the treatment and the control groups were assessed by of the forelimb (Fig. 1E). In the somites, cyr61 gene expres-
one-way ANOVA, followed by the Student's t test. Differences sion has been found to progress in a craniocaudal fashion,
were considered statistically signi®cant at the P  0.05 level. All coincident with the timing of chondrogenic differentiation
results were expressed as mean { standard error of the mean (SEM) (O'Brien and Lau, 1992). Likewise, the Cyr61 protein was
of six cultures per group except for the suspension aggregation ex-
localized in the less mature, condensing mesenchyme ofperiments, which had three to six cultures per group. Experiments
the caudal somites as they differentiate into chondrocyteswere repeated three times with similar results.
(Fig. 1F). In the more mature cranial region, Cyr61 was de-
tected in and around the differentiated vertebral cartilage.
These results show that Cyr61 is accumulated in vivo in
RESULTS the developing skeleton, consistent with its potential role
in chondrogenesis.
Cyr61 protein was also detected in isolated mouse limbLocalization of Cyr61 in limb bud mesenchyme. Expres-
sion of the cyr61 gene during mouse embryonic develop- mesenchymal cells throughout the 4-day culture period dur-
ing which chondrogenesis occurred (Fig. 2). Using quantita-ment is closely correlated with chondrogenesis as detected
by in situ hybridization (O'Brien and Lau, 1992). Consistent tive immunoblot analysis, we estimated Cyr61 to represent
approximately 0.03% of total cellular and extracellular pro-with this ®nding, the Cyr61 protein was immunohisto-
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FIG. 3. Immunohistochemical localization of Cyr61 in limb mesenchymal cells in micromass culture. Cells (5 1 106 cell/ml) were plated
on glass coverslips and analyzed on culture day 3 with primary antibodies against Cyr61 (B), tenascin (C), and ®bronectin (D) and FITC-
conjugated goat anti-rabbit secondary antibodies. Cells treated with anti-Cyr61 antibodies neutralized with 1 mg/ml puri®ed Cyr61 protein
were used as a control (A). Bar, 65 mm.
teins of the initial mesenchymal micromass culture (data to mediate adhesion in limb mesenchymal cells, we com-
pared their attachment on non-tissue culture dishes coatednot shown). In the differentiating micromass, Cyr61 and
tenascin were primarily localized among the cells in the with BSA, Cyr61, tenascin, and ®bronectin (Fig. 4). Cells
attached poorly to BSA-coated dishes (Fig. 4A), but adheredcartilage nodule (Figs. 3B and 3C), while ®bronectin was
localized around and between the nodules (Fig. 3D). To- as clusters of rounded cells to Cyr61- and tenascin-coated
dishes within 1 h of plating (Figs. 4C and 4E). In contrast,gether, these results show that endogenous Cyr61 is local-
ized in the mesenchyme of the limb bud and somites during cells plated on ®bronectin-coated dishes attached uniformly
and began to spread (Fig. 4G). When cells were allowed tochondrogenesis in vivo and during chondrogenic differentia-
tion in vitro (Figs. 1±3). attach for 3 h, many more adherent cells were observed on
all protein substrates (Figs. 4D, 4F, and 4H), except for BSACyr61 promotes cellular adhesion and intercellular ag-
gregation in limb mesenchyme. Cyr61 is a secreted, ECM- (Fig. 4B). The degree of cell adhesion was quanti®ed by
counting the number of adherent cells in three separateassociated protein that can mediate the adhesion of ®bro-
blasts and endothelial cells to non-tissue culture-treated ®elds on each substrate. At 1 h after plating, the number of
adherent cells per ®eld (mean { SEM) was similar betweensurfaces (Kireeva et al., 1996). To assess the ability of Cyr61
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FIG. 4. Limb mesenchymal cell adhesion to non-tissue culture-treated dishes coated with BSA (A and B), Cyr61 (C and D), tenascin (E and
F), and ®bronectin (G and H). Cells were allowed to adhere for either 1 h (A, C, E, and G), or 3 h (B, D, F, and H), after which nonadherent
cells were removed and the remaining adherent cells were photographed. Cells adhering to Cyr61 and tenascin clustered together and had a
rounded morphology (C±F), while those plated on ®bronectin began to spread to form a monolayer (G and H). Bar, 60 mm.
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Cyr61 (50 { 4), tenascin (65 { 7), and ®bronectin (84 { 7),
while a minimal number of cells adhered to BSA (6 { 1).
At 3 h after plating, the number of adherent cells was also
similar between Cyr61 (550 { 42), tenascin (563 { 67), and
®bronectin (520 { 43), while cell adhesion to BSA remained
minimal (12 { 1). Intercellular clustering and rounded cell
morphology were maintained in cells plated on Cyr61 and
tenascin (Figs. 4D and 4F), while cells plated on ®bronectin
spread to form a monolayer (Fig. 4H). It is important to note
that the maintenance of a rounded morphology, as rendered
by tenascin (Mackie et al., 1987), has been found to be con-
ducive for mesenchymal cell chondrogenesis in vitro (So-
lursh et al., 1982).
Since aggregation is an essential step for chondrogenic
differentiation (Solursh, 1984), we assessed the ability of
Cyr61 to mediate intercellular aggregation in single-cell
suspension cultures of mesenchymal cells. The number of
single cells remaining at various times after isolation were
counted. Untreated mesenchymal cells in suspension began
to aggregate soon after isolation, as the number of single
cells was decreased to 30% of the initial number within a
2-h incubation period (Fig. 5). Cell aggregation was signi®-
cantly inhibited in cultures treated with af®nity-puri®ed
anti-Cyr61 antibodies (Fig. 5A), indicating that endogenous
Cyr61 is important for mesenchymal cell aggregation. To
rule out the possibility that the af®nity-puri®ed anti-Cyr61
antibodies might contain unde®ned components that inter- FIG. 5. Endogenous Cyr61 mediates mesenchymal cell aggrega-
tion in suspension culture. Single-cell suspensions (1 1 106 cell/fere with aggregation, the antibodies were preincubated
ml) were incubated in serum-free medium; at successive timewith puri®ed Cyr61 protein prior to addition to cells. These
points, the numbers of single cells were counted in three ®elds perpreincubated antibodies affected cell aggregation no more
well, in each of three to six wells per group. (A) The numbers ofthan the IgG and Cyr61 buffer control (Fig. 5B), indicating
single cells as percentages of the initial culture at various timesthat the anti-Cyr61 antibodies indeed achieved their inhibi-
are shown for either untreated cultures (control) or cultures treatedtion of cell aggregation by neutralizing the endogenous
with anti-Cyr61 antibodies (Ab) or with 8 ml of 0.1 mg/ml rabbit
Cyr61 protein of mesenchymal cells. IgG (IgG). (B) Cell aggregation of untreated cultures (control) was
In addition, we examined the effect of Cyr61 on mesen- compared to cultures treated with af®nity-puri®ed anti-Cyr61 anti-
chymal cell aggregation in micromass cultures. When puri- bodies, which were incubated with 1 mg/ml BSA in Cyr61 buffer
®ed Cyr61 protein (0.3 mg/ml) was added to limb mesenchy- (Ab / 61 buffer). As additional controls, anti-Cyr61 antibodies pre-
incubated with puri®ed 1 mg/ml Cyr61 protein (Ab/Cyr61) or IgGmal cells, precocious cellular aggregation was observed
with BSA in Cyr61 buffer (IgG/61 buffer) were added. Values re-compared to controls within 24 h (Figs. 6A and 6B). At
ported are the numbers of single cells remaining at each time point,this time, neither Cyr61-treated nor control cultures had
expressed as a mean percentage {SE of the number at time 0 ofdifferentiated into cartilage nodules. By culture day 3, the
three to six cultures. Similar results were obtained in three separatedevelopment of internodular cellular condensations be-
experiments.tween the distinct cartilage nodules was more extensive in
Cyr61-treated cultures (Figs. 6C and 6D). These internodu-
lar condensations subsequently undergo chondrogenesis,
observed as Alcian blue-staining cartilaginous matrix on but reproducible and statistically signi®cant (P  0.01), ef-
fect on cell proliferation as re¯ected by both an increase inculture day 4 (Figs. 6E and 6F). Taken together, the results
of Figs. 4 to 6 indicate that Cyr61 is able to promote cell± cell number (Fig. 7A) and [3H]thymidine incorporation (Fig.
7B). This effect was not seen in cultures of later stages (daycell aggregation, a necessary step in chondrogenesis of mes-
enchymal cells in micromass culture. 4), as terminally differentiated chondrocytes ceased to di-
vide. These results show that the effect of Cyr61 on limbEffects of Cyr61 on cell proliferation and DNA synthesis.
To evaluate whether alteration in cell number might con- mesenchymal cell proliferation is modest and is not likely
to play a major role in the above observations (Fig. 6). Sincetribute to the above observations, we tested the effects of
Cyr61 on cell proliferation, since Cyr61 was found to en- this mitogenic effect can be quanti®ed, it is possible to
separate the effects of Cyr61 on proliferation from otherhance growth factor-induced DNA synthesis in ®broblasts
and endothelial cells (Kireeva et al., 1996). Puri®ed Cyr61 activities of Cyr61, such as promotion of chondrogenesis
(see Table 1 and below).protein added to limb mesenchymal cells exhibited a small,
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FIG. 6. Cyr61 promotes cell aggregation in micromass cultures. Limb mesenchymal cells were plated at 5 1 106 cell/ml and treated
with 0.3 mg/ml Cyr61 (B, D, and F) or its buffer (A, C, and E). (A and B) Hematoxylin-stained cultures on day 2; the staining patterns show
precocious cell aggregation in Cyr61 treated cells. Bar, 1.1 mm. (C and D) Photomicrographs of cells on culture day 3. A high level of cell
aggregation in between cartilage nodules in Cyr61-treated cultures is evident (D). Bar, 0.2 mm. (E and F) Alcian blue-stained cultures on
day 4, showing more extensive cartilage formation. Magni®cation is the same as in A and B.
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TABLE 1
Effect of Cyr61 on [35S]Sulfate Incorporation, Normalized
to Cell Number
Culture Cyr61 Fold
day Control (0.3 mg/ml) increase
2 4.5 { 0.5 2.3 { 0.3* 0.5
3 6.7 { 0.3 6.9 { 0.5 1.0
4 10.3 { 0.9 14.9 { 2.1* 1.5
8 13.5 { 1.3 33.1 { 2.7* 2.5
Note. Micromass cultures were plated at 5 1 106 cells/ml and
cultured in the presence or absence (control) of Cyr61 (added after
the 1 day of culture). [35S]Sulfate incorporation (cpm) determined
on culture day 4 was normalized to cell number and listed; all
ratios were multiplied by 1000.
* Statistically signi®cant difference (P  0.05).
sults suggest that Cyr61 acts effectively to promote chon-
drogenesis at the early stages of differentiation.
Cyr61 treatment also expanded the Alcian blue-staining
nodules in the differentiated micromass cultures (Fig. 6),
indicative of enhanced synthesis of cartilaginous matrix.
The differentiation of chondroblasts into chondrocytes is
accompanied by the synthesis of a large amount of sulfated
proteoglycans (Solursh, 1991), which can be evaluated quan-
titatively by monitoring the incorporation of [35S]sulfate
FIG. 7. Effect of Cyr61 on cell proliferation. (A) Cell number in (San Antonio et al., 1987; San Antonio and Tuan, 1986;
limb mesenchymal cell micromass cultures, plated at 5 1 106 cell/
ml, was determined at the indicated days in culture. Puri®ed Cyr61
(0.3 mg/ml) (squares) or Cyr61 buffer (circles) was given after the
®rst 24 h of culture (day 1). (B) Cultures were exposed to [3H]-
thymidine for 18 h on each of culture days 1 to 4. Values represent
mean cpm {SE of six cultures. Asterisks denote statistically sig-
ni®cant differences from controls (P  0.05).
Cyr61 enhances chondrogenic differentiation. As de-
scribed above, Cyr61 protein promotes mesenchymal cell
aggregation (Figs. 4±6), a ®rst and prerequisite step for
chondrogenic differentiation. The condensed mesenchy-
mal cells differentiate into chondroblasts, which express
type II collagen, prior to their terminal differentation into
chondrocytes (Dessau et al., 1980; Castagnola et al.,
1988). To evaluate further the ability of Cyr61 to promote
chondrogenesis, we examined its effect on the expression
of type II collagen (Fig. 8). The addition of Cyr61 to the
FIG. 8. Cyr61 stimulates type II collagen expression. Micromassmicromass culture 1 day after plating resulted in a sig-
cultures of limb mesenchymal cells were cultured in the presenceni®cant enhancement of type II collagen expression
(/) or absence (0) of Cyr61 (5 mg/ml), added after the ®rst day ofwithin 24 h (day 2 of culture), while expression in buffer-
culture. Total RNA was isolated on culture days 1, 2, and 4 and
treated control cells was still at the background level (Fig. electrophoresed for Northern blot analysis. The blot was probed
8). Thus Cyr61 treatment accelerated the differentiation with 32P-labeled cDNA probe against the a1 chain of the mouse
of mesenchymal cells into chondroblasts. Taken together type II collagen (pMCol2a1; top) and subsequently stripped and
with the ability of Cyr61 to stimulate the precocious cel- rehybridized with radiolabeled cDNA against b-tubulin for normal-
ization of RNA loading (bottom).lular aggregation and nodule formation (Fig. 6), these re-
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FIG. 9. Cyr61 promotes chondrogenesis. Limb mesenchymal cell micromass cultures (plated at 5 1 106 cell/ml) were treated with (A)
Cyr61 buffer (control) or (B) 0.3 or (C) 5 mg/ml Cyr61 and stained with Alcian blue on culture day 4. Bar, 0.5 mm. (D) [35S]Sulfate
incorporation was determined on culture day 4 in cultures treated with various doses of Cyr61 as indicated. No signi®cant difference was
observed between untreated cultures (none) and cultures treated with Cyr61 buffer (0), whose sulfate incorporation was set to 100%.
Values represent mean cpm {SE of six cultures. Asterisks denote statistically signi®cant differences from buffer controls (P  0.05).
Hascall et al., 1976). Exogenously added Cyr61 enhanced of the large cartilage nodules which were formed at this
dose detached from the dish (Fig. 9C). Cultures treated with[35S]sulfate incorporation in a dose-dependent manner, re-
sulting in a 1.5- and 3.5-fold increase with 0.3 and 5 mg/ 10 mg/ml Cyr61 formed even more massive mounds of carti-
lage (data not shown). Our results show that puri®ed Cyr61ml Cyr61, respectively (Fig. 9D). This increase in sulfate
incorporation was correlated qualitatively with enhanced was effective in promoting chondrogenesis at concentra-
tions (10±100 nM; Fig. 9) similar to or less than those ofAlcian blue staining (Figs. 9B and 9C). The increase ob-
served at the 5 mg/ml Cyr61 dose (120 nM) is an underesti- other molecules known to act in the mesenchymal cell mi-
cromass system. For example, chondrogenesis in limb mes-mation of the actual extent of chondrogenesis, since some
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TABLE 2 plated in a high-density micromass, the extent of chon-
Effects of Cyr61 on [35S]Sulfate Incorporation in Cells Plated at drogenesis may be maximal and cannot be enhanced fur-
Different Densities ther by exogenous factors. However, even when cells were
plated at high densities (3 to 10 1 106 cell/ml), the addi-
Cell density Cyr61 Fold tion of exogenous Cyr61 resulted in a twofold enhance-
(cell/ml) Control (0.3 mg/ml) increase
ment in [35S]sulfate incorporation (Table 2). Therefore,
Cyr61 can further enhance chondrogenesis in high-den-2.5 1 106 42 { 3 226 { 63* 6.3
3 1 106 122 { 4 280 { 40* 2.4 sity micromass cultures, which have apparently not
5 1 106 683 { 26 1320 { 42* 1.9 reached a maximal degree of differentiation.
10 1 106 6071 { 331 11697 { 1133* 1.9 Neutralizing anti-Cyr61 antibodies directed against en-
dogenous Cyr61 inhibit chondrogenesis. The presence of
Note. Micromass cultures were plated at the indicated densities,
endogenous Cyr61 in mesenchymal cells, both in vivo andand Cyr61 protein, where indicated, was added 1 day after culture.
in vitro (Figs. 1±3), indicates that Cyr61 may indeed func-[35S]Sulfate incorporation (cpm) was determined on culture day 4.
tion biologically to regulate chondrogenic differentiation* Statistically signi®cant difference (P  0.05).
(O'Brien and Lau, 1992). The abilities of exogenously added
puri®ed Cyr61 to promote intercellular aggregation (Figs. 5
and 6) and to increase [35S]sulfate incorporation and Alcian
blue staining (Figs. 6 and 9; Table 1) demonstrate that Cyr61enchymal cells was increased 2-fold with the addition of 10
mg/ml heparin (400 nM; San Antonio et al., 1987) and 3- can act as a chondrogenesis-enhancing factor. Since neu-
tralizing anti-Cyr61 antibodies have been described (Kireevafold with 50 mg/ml tenascin (200 nM; Mackie et al., 1987).
It is possible that the increased [35S]sulfate incorpora- et al., 1996, 1997), we used these antibodies to assess the
role of Cyr61 endogenously produced in these cells in chon-tion in Cyr61-treated cultures (Fig. 9) might be due to an
increase in cell number, although the effect of Cyr61 on drogenesis. Anti-Cyr61 antibodies were added to the mesen-
chymal cell culture media or mixed with the cell suspen-cell proliferation is small (Fig. 7). Any possible effect of
cell proliferation, however, can be eliminated by normal- sion prior to plating. Chondrogenesis was inhibited in the
anti-Cyr61 antibodies-treated cultures, as demonstrated byization of sulfate incorporation with respect to cell num-
ber. Cultures treated with a nonsaturating dose of Cyr61 the decrease of [35S]sulfate incorporation to 50% of controls
when antibodies were added to the media (Fig. 10D) and to(0.3 mg/ml) still showed an approximately twofold in-
crease in normalized sulfate incorporation over control 30% of controls when mixed with the cells before plating
(Fig. 10E). These observations were correlated with substan-(Table 1), indicating that Cyr61 promotes a net increase
in chondrogenesis independent of effects on cell number. tially decreased Alcian blue staining (Fig. 10A±C). How-
ever, mixing of the anti-Cyr61 antibodies with mesenchy-On culture day 2, the sulfate/cell number ratio was lower
in Cyr61-treated cultures compared to controls (Table 1) mal cells prior to plating resulted in detachment in some
of the treated cultures within 24 h. To eliminate the possi-and is re¯ective of a low level of [35S]sulfate incorporation
relative to cell number. This is because cell proliferation bility that an unidenti®ed component in the antibody prepa-
ration may be a cause of cell detachment, anti-Cyr61 anti-occurs mostly in the ®rst day of culture while differentia-
tion occurs over a later period (Ede, 1983). body was preincubated with puri®ed Cyr61 protein prior
to mixing with cells. The inhibiting effects of anti-Cyr61Cyr61 promotes chondrogenesis at various cell densities.
Since a certain threshold cell density must be reached for antibodies in chondrogenesis were abolished by neutraliza-
tion with Cyr61 protein (Fig. 10E). Taken together, theseinitial aggregation to occur (Umansky, 1966; Ahrens et al.,
1977), embryonic mesenchymal cells plated at low densities results demonstrate that endogenous Cyr61 present in mes-
enchymal cells plays an important role for their chondro-are normally unable to differentiate into chondrocytes, al-
though the addition of exogenous factors such as heparin genesis.
or poly-L-lysine (San Antonio and Tuan, 1986; San Antonio
et al., 1987) has been shown to support chondrogenesis in
cells plated under these conditions. Therefore, we assessed
DISCUSSIONthe ability of Cyr61 to promote differentiation of mesenchy-
mal cells plated at densities above and below the threshold
for chondrogenesis. Cells plated at 2.5 1 106 cell/ml incor- Observations on the tissue-speci®c and temporally re-
stricted expression of cyr61 during mouse embryogenesisporated little [35S]sulfate (Table 2). However, when Cyr61
was added, these subthreshold density cultures formed nod- provided the initial clues that Cyr61 might be involved in
skeletal development (O'Brien and Lau, 1992). Further stud-ules and incorporated sulfate to a level similar to that in
cultures plated at 3 1 106 cell/ml, which is permissive for ies showed that puri®ed Cyr61 protein promotes cell prolif-
eration, migration, and adhesion (Kireeva et al., 1996)Ðchondrogenesis (Table 2). Therefore, Cyr61 can support
chondrogenesis in mesenchymal cells plated at nonchon- activities consistent with those of a regulator of cell growth
and differentiation. These ®ndings form the basis for thedrogenic, subthreshold densities.
It is conceivable that when mesenchymal cells are present study in which we show directly that the Cyr61
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8766 / 6x32$$$101 12-05-97 11:36:46 dba
504 Wong et al.
FIG. 10. Anti-Cyr61 antibodies inhibit chondrogenesis. Limb mesenchymal cell micromass cultures (7 1 106 cell/ml) were maintained
for 4 days. Cultures were treated with (A) IgG or (B) 10 or (C) 13 ml of anti-Cyr61 antibodies in the media and stained with Alcian blue.
Bar, 0.8 mm. [35S]Sulfate incorporation was determined on culture day 4 in cultures with anti-Cyr61 antibodies in the media (D) or mixed
with the cells prior to plating (E). In (D), controls were untreated (None) or treated with rabbit IgG. In (E), controls included: (1) rabbit
IgG preincubated with Cyr61 buffer, (2) Cyr61 protein preincubated with rabbit IgG, and (3) anti-Cyr61 antibodies preincubated with 1
mg/ml puri®ed Cyr61 protein. Values represent mean cpm {SE of six cultures. Asterisks denote statistically signi®cant difference from
buffer controls (P  0.05).
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protein plays a role in modulating chondrogenesis in mouse against them partially inhibit chondrogenesis (Downie
and Newman, 1995; Mackie et al., 1987; Oberlender andembryonic limb mesenchymal cells.
We conclude that Cyr61 is a previously unknown par- Tuan, 1994; Widelitz et al., 1993). Both NCAM and N-
cadherin are integral membrane proteins that can directlyticipant in chondrogenic differentiation based on the fol-
lowing observations: (1) The cyr61 mRNA and protein are mediate cell±cell aggregation by homophilic interactions
with the same proteins on adjacent cells, which in turnaccumulated in condensing mesenchymal cells concomi-
tant with their chondrogenic differentiation both in vivo leads to cytoskeletal changes conducive for differentia-
tion (Ruoslahti and Obrink, 1996). In contrast, the activi-and in vitro (Figs. 1±3) (O'Brien and Lau, 1992). (2) Cyr61
protein promotes cell aggregation, which contributes to ties of ®bronectin and tenascin on chondrogenesis appear
to be correlated with their effects on cell shape. Whilechondrogenic differentiation (Figs. 4±6). (3) Cyr61 accel-
erates the differentiation of mesenchymal cells into chon- ®bronectin can inhibit chondrogenic differentiation by
causing cell ¯attening (Swalla and Solursh, 1984), tenas-droblasts as judged by the precocious expression of type
II collagen (Fig. 8). (4) Cyr61 promotes chondrogenesis as cin has been proposed to enhance chondrogenesis by
counteracting the effects of ®bronectin (Mackie et al.,judged by increased Alcian blue staining and [35S]sulfate
incorporation (Figs. 6 and 9; Table 1). Furthermore, Cyr61 1987; Chiquet-Ehrismann et al., 1988). These observa-
tions indicate that the initial cell aggregation to formsupports chondrogenesis even in cells plated at subthresh-
old densities that are otherwise unable to differentiate mesenchymal condensations requires the interaction be-
tween several extracellular matrix proteins and cell adhe-(Table 2). (5) Neutralization of the endogenous Cyr61 pro-
tein in mesenchymal cells by speci®c anti-Cyr61 antibod- sion molecules, which in turn may be regulated by growth
factors and other signaling proteins that control morpho-ies inhibits chondrogenesis (Fig. 10). Taken together,
these lines of evidence show that Cyr61 plays a role in genesis and tissue patterning.
Cyr61 stimulates the precocious expression of type IIcartilage formation in mammalian embryonic skeletal de-
velopment. collagen (Fig. 8), a marker for chondroblasts (Dessau et
al., 1980; Castagnola et al., 1988). This result indicatesThese chondrogenic activities can be attributed to the
Cyr61 polypeptide by reason of the following observa- that Cyr61 not only acts to promote cell aggregation, but
also accelerates the differentiation of mesenchymal cellstions: (1) The recombinant mouse Cyr61 protein prepara-
tion was puri®ed to near homogeneity as judged by SDS± into chondroblasts prior to their maturation into chon-
drocytes. In later stage micromass cultures, Cyr61 alsopolyacrylamide gel electrophoresis (Fig. 2B), using a well-
characterized method of puri®cation (Kolesnikova and increases the amount of Alcian blue staining and [35S]-
sulfate incorporation, both indicative of increased synthe-Lau, 1998; Kireeva et al., 1996, 1997). (2) Cyr61 was puri-
®ed from serum-free conditioned media of insect cells, sis of sulfated proteoglycans in cartilage-speci®c matrix
(Figs. 6 and 9; Table 1). These results indicate that Cyr61which do not produce any known chondrogenic protein.
(3) The chondrogenic activities of Cyr61 (Figs. 5 and 10) not only accelerates the rate of differentiation, but also
increases the extent of differentiation in limb mesenchy-can be inhibited by highly speci®c anti-Cyr61 antibodies
that do not cross-react even with a structurally related mal cells.
Understanding how Cyr61 acts mechanistically mayfamily member puri®ed in a similar fashion (Kireeva et
al., 1996, 1997). depend upon the identi®cation of its cell surface receptor.
Cyr61 has been shown to promote cell adhesion and mi-The initial step of chondrogenesis involves cell±cell
aggregation to form mesenchymal condensations, where gration and to enhance growth factor-induced DNA syn-
thesis (Kireeva et al., 1996). It is thus possible that Cyr61cyr61 expression is detected in the developing embryo
(Fig. 1) (O'Brien and Lau, 1992). Studies on chondrogen- might bind to integrin receptors, which are known to me-
diate the aforementioned activities (Ruoslahti andesis in vitro using the micromass system have revealed
that both a threshold cell density (Ahrens et al., 1977; Obrink, 1996; Schwartz et al., 1995). Both ®bronectin and
tenascin are known to bind integrins (Sriramarao et al.,Umansky, 1966) and a rounded cell morphology are essen-
tial for differentiation and maintenance of the cartilage 1993; Schnapp et al., 1995), which may mediate their
mechanism of action. It is also possible that Cyr61, aphenotype (Benya and Shaffer, 1982; Solursh et al., 1982).
In these regards, Cyr61 can act at the early phase of chon- heparin-binding protein, might act through interactions
with heparan sulfate proteoglycans. Tenascin can alsodrogenesis by promoting cell±cell aggregation, main-
taining a rounded cell morphology, and supporting chon- bind to the cell surface heparan sulfate proteoglycan syn-
decan, which is expressed in the condensing skeletal mes-drogenesis in subthreshold density cultures (Figs. 4±6;
Table 2). Other molecules known to be involved in the enchyme (David et al., 1993; Bern®eld et al., 1992). The
possibility that integrins and/or syndecans may act ascell aggregation phase of chondrogenesis include ®bro-
nectin (Frenz et al., 1989; Downie and Newman, 1995), Cyr61 receptors in mediating mesenchymal cell chondro-
genesis remains to be examined.tenascin (Mackie et al., 1987), N-cadherin (Oberlender
and Tuan, 1994), and NCAM (Widelitz et al., 1993). Like The identi®cation of Cyr61 as a novel participant in
mammalian chondrogenesis allows future studies to inte-Cyr61, these molecules have been localized to the con-
densing limb mesenchyme, and antibodies directed grate the interplay between Cyr61 with various ECM mol-
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family of transmembrane heparan sulfate proteoglycans. Annu.ecules and growth factors in skeletal development. It is
Rev. Cell Biol. 8, 365±393.known that TGFb can promote mesenchymal cell chon-
Bork, P. (1993). The modular architecture of a new family of growthdrogenesis alone or synergistically with bFGF (Scho®eld
regulators related to connective tissue growth factor. FEBS Lett.and Wolpert, 1990; Kulyk et al., 1989; Leonard et al.,
327, 125±130.1991; Jiang et al., 1993). Since cyr61 expression is acti-
Bradham, D. M., Igarashi, A., Potter, R. L., and Grotendorst, G. R.
vated as an immediate-early response to TGFb and bFGF (1991). Connective tissue growth factor: A cysteine-rich mitogen
(Brunner et al., 1991; O'Brien et al., 1990), Cyr61 may act secreted by human vascular endothelial cells is related to the
as a mediator of growth factor actions to regulate subse- SRC-induced immediate early gene product CEF-10. J. Cell Biol.
quent cellular events. Recent studies point to the bone 114, 1285±1294.
morphogenetic proteins (BMPs), which are members of Brunner, A., Chinn, J., Neubauer, M., and Purchio, A. F. (1991).
Identi®cation of a gene family regulated by transforming growththe TGFb superfamily, as playing key roles in skeletal
factor-beta. DNA Cell Biol. 10, 293±300.development. BMP-2 and BMP-3 increase chondrogenesis
Carrington, J. L., Chen, P., Yanagishita, M., and Reddi, A. H. (1991).in micromass cultures of limb mesenchymal cells (Car-
Osteogenin (bone morphogenic protein-3) stimulates cartilagerington et al., 1991; Duprez et al., 1996a), similar to the
formation by chick limb bud cells in vitro. Dev. Biol. 146, 406±effects of Cyr61. That members of the TGFb and BMP
415.families of proteins may regulate cyr61 expression as part
Castagnola, P., Dozin, B., Moro, G., and Cancedda, R. (1988).
of their activities in skeletal development is an intriguing Changes in the expression of collagen gene show two stages in
possibility that warrants further investigation. chondrocyte differentiation in vitro. J. Cell Biol. 106, 461±467.
Current research on the molecular mechanisms of limb Chiquet-Ehrismann, R., Kalla, P., Pearson, C. A., Beck, K., and Chi-
development focuses on the interplay between Sonic quet, M. (1988). Tenascin interferes with ®bronectin action. Cell
Hedgehog (Shh), FGFs, BMPs, and the homeobox-con- 53, 383±390.
David, G., Bai, X. M., Van der Schueren, B., Marynen, P., Cassiman,taining Hox family proteins. Shh and BMP-2 in the mes-
J. J., and Vanden Berghe, H. (1993). Spatial and temporal changesenchyme, along with FGF-4 from the limb ectoderm, reg-
in the expression of ®broglycan (syndecan-2) during mouse em-ulate the expression of the Hox gene products (Laufer et
bryonic development. Development 119, 841±854.al., 1994; Duprez et al., 1996b), which are involved in
Dessau, W., von der Mark, H., von der Mark, K., and Fischer, S.skeletal patterning by modulating cell±cell adhesions
(1980). Changes in the patterns of collagens and ®bronectin dur-that lead to chondrogenesis (Yokouchi et al., 1991, 1995).
ing limb-bud chondrogenesis. J. Embryol. Exp. Morph. 57, 51±
In addition, Shh, BMP-2, and FGF-4 regulate one anothers' 60.
expression to integrate limb outgrowth and mesenchymal Downie, S. A., and Newman, S. A. (1995). Different roles for ®bro-
patterning (Laufer et al., 1994; Duprez et al., 1996b). It is nectin in the generation of fore and hind limb precartilage con-
tempting to speculate that Cyr61, synthesized as a growth densations. Dev. Biol. 172, 519±530.
factor-inducible immediate-early gene product, acts as a Duprez, D. M., Coltey, M., Amthor, H., Brickell, P. M., and Tickle,
C. (1996a). Bone morphogenetic protein-2 (BMP-2) inhibits mus-downstream mediator of BMPs, FGFs, and/or Shh to mod-
cle development and promotes cartilage formation in chick limbulate mesenchymal cell interactions.
bud cultures. Dev. Biol. 174, 448±452.
Duprez, D. M., Kostakopoulou, K., Francis-West, P. H., Tickle, C.,
and Brickell, P. M. (1996b). Activation of Fgf-4 and hoxD gene
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